START DATE AND DURATION: June 2023 - June 2026
Summary
Surgical resection is the mainstay curative treatment for early stage non-small cell lung cancer, oesophageal squamous cell carcinoma, and muscle-invasive bladder cancer.
Radical radiotherapy (RT) is a recommended alternative, but there is limited trial evidence comparing curative RT with surgery.
This NIHR-funded study will describe the influence of patient and organisational factors on the use of curative treatment, assess inequalities in the receipt of curative versus non-curative interventions, and assess the effectiveness and cost-effectiveness of curative RT versus curative surgical strategies using linked routine cancer data.
